Merck fails in late-stage trial for Keytruda combo in colon cancer
Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...
Merck says trial of combination treatment for colon cancer failed to meet main goal
Merck & Co.'s stock fell 0.5% premarket Wednesday, after the drug company said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet the main goal ...
Bristol, Merck checkpoint inhibitors focus of FDA advisory committee meeting
Opdivo (nivolumab) and Merck's (NYSE:MRK) Keytruda (pembrolizumab), two highly popular checkpoint inhibitors used in the ...
The New York Times18h
New York Times - Top Stories
In U.N. Speech, Biden Says World Faces an ‘Inflection Point’ Amid Turmoil The U.N. General Assembly has begun in New York City as conflicts rage across the world. In his final U.N. speech ...
Indiatimes12h
WORLD NEWS
Thailand's King has endorsed a historic marriage equality bill passed by parliament on June 18. Effective January 22, 2025, this law makes Thailand the first Southeast Asian country to legalise ...
Greek Reporter12h
Greek News
Prime Minister Kyriakos Mitsotakis honored prominent Greek Americans for their contributions to the community during a reception in Astoria on September 24. Mike Manatos, Executive Director of the ...